Skip to main content
. 2015 Jan 21;10(1):e0116344. doi: 10.1371/journal.pone.0116344

Table 1. Clinicopathologic Characteristics.

Variables Triple-Negative Cancer (n = 256) ER-Positive Cancer (n = 846) P value
Age (y)a 51 (20 – 78) 52 (22 – 84) .069
Family history of breast cancer 26 (10.2) 47 (5.6) .014
Palpability < .0001
No 60 (23.4) 379 (44.8)
Yes 196 (76.6) 467 (55.2)
Mammographic breast density .934b
Grade 1 25 (9.8) 75 (8.9)
Grade 2 56 (21.9) 185 (21.9)
Grade 3 127 (49.6) 436 (51.5)
Grade 4 48 (18.8) 150 (17.7)
Mammographic visibility .151
No 19 (7.4) 83(9.8)
Yes 237(92.6) 763(90.2)
Histologic type
Invasive ductal 235 (91.8) 755 (89.2) .288
Invasive lobular 0 45 (5.3) < .0001
Mucinous 0 32 (3.8) < .0001
Metaplastic 13 (5.1) 0 < .0001
Tubular 0 5 (0.6) .596
Apocrine 4 (1.6) 0 .003
Adenoid cystic 2 (0.8) 0 .054
Invasive papillary 1 (0.4) 6 (0.7) 1.000
Invasive micropapillary 0 2 (0.2) 1.000
Medullary 1 (0.4) 1 (0.1) .411
Tumor size(cm)a 2.2 (0.2 – 5.4) 1.9 (0.2 – 5.9) < .0001
Histologic grade < .0001b
I 2 (0.8) 125 (14.8)
II 35 (13.7) 478 (56.5)
III 219 (85.5) 243 (28.7)
Axillary nodal status .001
Negative 216 (84.4) 628 (74.2)
Positive 40 (15.6) 218 (25.8)
Surgery .628
Breast-conserving surgery 212 (82.8) 712 (84.2)
Mastectomy 44 (17.2) 134 (15.8)

Unless otherwise indicated, data are numbers of patients and numbers in parentheses are percentages.

aData are mean values, with ranges in parentheses.

bChi-square test for trend.